Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • thinkRNA
    Member
    • Jan 2010
    • 94

    RNA-seq Analysis 101

    I am starting out analyzing unpaired Illumina RNA-seq reads to determine differential expression between two samples (and eventually want to look at alternative splicing).

    From all my reading so far, it seems these are the step to follow and there are TONS of programs for each step. There are also integrated softwares out there which will supposedly do all these for you.

    The thread here is to find out (1) Are these steps right? (2) Which programs work the best for all of you. I am asking the masters out there, what worked for them and to fill in the gaps.

    Steps:
    (1) Obtain a data set, preferably a small set your computer and brain can handle. Tons of data available now in NCBI Trace archive.
    (2) Align it to the reference genome (I am using Bowtie, I know there are many other software). Tweak the parameters and get maximum reads aligned. Understand what is happening to unmapped reads as well as the mapped reads. Get familiar with output. Ultimately get it in a format you understand. I am using SAM format. This step is critical, I think.
    (3) Since I am interested in alternative splicing, I plan on using Tophat (which uses Bowtie) to align reads to known junctions. In the future, I plan on providing my own set of junctions.
    (4) Determine differential expression. Which program is best for this and has worked well?? Cufflinks, DegSeq. I understand that this is step where you will perform any normalization and implement complex statistics (Poisson or determine likelihood) to determine if a gene is differentially expressed between two samples. Which program has worked well for you, what are the pros and cons?
    (5) Use a visualization tool to look at your data. you can also do this after step (2)

    So, does this sound right? What are the challenges in analyzing RNA-seq data, besides choosing from a large number of options. I am more interested in knowing from people who have successfully determined differential expression of genes which step requires caution and is time consuming, where in lies the challenge?
  • steven
    Senior Member
    • Aug 2009
    • 269

    #2
    Originally posted by thinkRNA View Post
    The thread here is to find out (1) Are these steps right?
    Looks pretty good!
    Some more info maybe in this paper (nature methods).

    Comment

    • crazyhottommy
      Senior Member
      • Apr 2012
      • 187

      #3
      The best way is trying out the whole process by yourself. Mapping by Tophat may be tricky sometimes...and it took me long time even I do it on the computing cluster...

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      28 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Working...